Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0085580 (essential hypertension)
 14,686 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Abnormalities in left ventricular (LV) diastolic function may be the earliest indications of hypertensive heart disease. Because the two ventricles influence each other's performance this study was designed to investigate the impact of chronic LV pressure overload in essential hypertension (HT) on diastolic function of right ventricle (RV). RV and LV diastolic function was evaluated in 74 patients with mild-to-moderate essential HT using pulsed wave Doppler echocardiography. Fifty-five normotensive patients without heart disease acted as control subjects. In studied group, 17 patients (23%) had normal mitral (MV) and tricuspid (TV) flow parameters, 28 (38%) had impaired LV filling parameters [MV early (E) to late (A) peak flow velocity ratio (MV E/A) 0.81 +/- 0.12 vs control 1.19 +/- 0.18, p < 0.001] while 29 patients (39%) had abnormal both mitral [MV E/A) 0.72 +/- 0.15 vs control 1.19 +/- 0.18, p < 0.001] and tricuspid flow parameters (TV E/A) 0.8 +/- 0.19 vs control 1.23 +/- 0.1, p < 0.001). In group with impaired diastolic filling of both ventricles indices of mitral flow were significantly more abnormal compared to group with normal TV flow parameters (MV E/A 0.72 +/- 0.15 vs control 0.81 +/- 0.12, p < 0.05). RV filling parameters correlated with filling parameters. There was good correlation between TV A and MV E (r = -0.56, p < 0.01), the time velocity integral of early mitral inflow (MV E-VTI) (r = -0.64, p < 0.001) and positive correlation with MV A (r = 0.78, p < 0.0001). Also there was good correlation between LV mass and TV E (r = -0.56, p < 0.01) and the time velocity integral of early tricuspid inflow (r = -0.72, p < 0.001). Data indicate that RV diastolic function is abnormal in essential hypertension and these abnormalities are closely related to those of LV diastolic function and LV mass.
Pol Arch Med Wewn 1997 Apr
PMID:[Right ventricular diastolic disfunction and its relation to left ventricular performance in patients with hypertension]. 941 9

The case of secondary hypertension to pheochromocytoma in 71 year old woman is described. This woman has been made a false diagnosis of primary hypertension 10 years earlier. The primary objective of this paper was to call practitioners' attention to the necessity of penetrating diagnosis of arterial hypertension, also in elderly patients. Over-hasty diagnosis of primary arterial hypertension hampers the possibility of proper and causal treatment. Labile and paroxysmal hypertension with headache, tachycardia and sweating should alert the clinician to tumor of the adrenal medulla as well as the extra-adrenal paraganglion system (pheochromocytoma is the cause of arterial hypertension in 0.1-1.0% of all cases). Twenty four hours excretion level of vanillylmandelic acid in urine is of diagnostic relevance for patients with pheochromocytoma. The measurement which is done after elevation of blood pressure is more sensitive.
Pol Merkur Lekarski 1997 Jul
PMID:[Secondary hypertension during a course of phaeochromocytoma in a 71-year old woman]. 943 94

The aim of the study was to evaluate the importance of time and frequency domain analysis of P-wave signal averaging, left atrium size measured echocardiographically and time of P.-wave assessed in II lead of standard ECG in patients with different frequency of atrial fibrillation events. The material consisted of 110 pts (81 men and 29 women), mean age 60.44 +/- 10.73 with atrial fibrillation events concomitant coronary heart disease and/or primary hypertension documented in standard ECG or Holter monitoring. The positive correlation, statistically significant between the frequency of atrial fibrillation events and the time of filtered P-wave vector, the time of filtered P-wave in X, Y, Z leads and differences between times of filtered P-wave vector and times of P-wave in II ECG lead was confirmed. Additionally the negative correlation, statistically significant between frequency of atrial fibrillation events and RMS10, RMS20 and RMS30 was confirmed. There was no correlation between frequency analysis of P-wave averaging or left size and frequency of atrial fibrillation events.
Pol Merkur Lekarski 1997 Aug
PMID:[Frequency of paroxysmal atrial fibrillation and parameters of averaged atrial signal]. 948 Jan 75

Endothelins (ETs) are peptides of 21 amino acids synthesized and released by variety of cells. Endothelin (now this peptide is called endothelin-1 (ET-1)) was isolated and identified in 1988 by Yanagisawa et al. Following studies revealed two other isoforms of endothelin': Endothelin-2 (ET-2) and endothelin-3 (ET-3). All of them bind to two types of receptors (A and B (ET-A r, ET-Br). ET-A r are responsible for concentration mediating. Two subtypes of ET-B r are known. ET-B1 r mediates vasorelaxation; ET-B2 vasoconstriction. ETs (especially ET-1) have variety of biological actions but the most important are vasoconstrictor and mitogenic action. Through these two mechanism ETs may participate in the pathogenesis and/or in the maintenance of hypertension in both experimental animal models and human essential hypertension. The intravenous infusion of synthetic ET induces a long-lasting elevation of blood pressure in experimental animals and in healthy humans. Number of studies have shown enhanced responses to ET in hypertensive subjects but decreased responses have also been reported. Similarly, plasma levels of ET-1 are either normal or elevated in experimental and human essential hypertension. Numerous investigators have suggested an interaction between ET and angiotensin-converting enzyme inhibitors through the renin-angiotensin system or through the accumulation of endogenous bradykinin. Also calcium antagonists of different classes prevent endothelin-induced contractions. Endothelin- converting enzyme inhibitor (phosphoramidon) and ET-A/B r antagonists (bosentan, BQ-123, FR139317) may have potential role as vasodilators in the treatment of hypertension.
Pol Merkur Lekarski 1998 Jan
PMID:[Endothelin and arterial hypertension]. 955 99

Paroxysmal atrial fibrillation (PAF) often accompany coronary heart disease (CHD), and primary hypertension (PH). The aim of the study was to evaluate the time of occurrence and duration of paroxysmal atrial fibrillation (PAF) identified from Holter recordings in 63 patients (27 women and 36 men) with CHD (n = 45) and PH (n = 18). No pharmacological treatment was applied before and during the examination. All patients were in sinus rhythm at the start and the end of the recording which lasted for 24 hours. PAF were defined as the occurrence of at least four beats of supraventricular origin, with no visible P or flutter waves. The time of onset, duration, ventricular rate and symptoms of each PAF were noted. There were 219 paroxysms recorded in 63 patients which occurred more often by day than by night, the time of duration was 0.9-240 s. Of the total, 16.3% of episodes with CHD and 9.5% episodes in patients with PH occurred between the hours 8:00-10:00 and between 16:00 and 18:00; 9.1% and 21% respectively. We concluded that in patients with CHD and with H most of the episodes (95%) are silent, they occurred more often during the day activity (particularly between the hours of 8:00 and 10:00 and 16:00-18:00 in both groups). In patients with CHD we observed the third peak of occurrence of PAF between the hours 22:00-0:00.
Pol Merkur Lekarski 1998 Jun
PMID:[Time of occurrence of paroxysmal atrial fibrillation in Holter monitoring in patients with coronary heart disease and in patients with hypertension]. 977 Oct 12

Both environmental and genetic factors are implicated in the pathogenesis of essential hypertension. The defect of the ANP precursor gene leading to the decrease of ANP synthesis are a cause of the development of sodium-sensitive hypertension in animals. Recent findings in African-Americans who are a model of sodium-sensitive population, reveal a strong association between Sma I polymorphism at intron 2 (the polymorphic site is identical for Hpa II restriction enzyme) or both Sma I and Sca I polymorphism at exon 3 of ANP precursor gene and essential hypertension. The aim of our study was to optimize the methods for Sma I and Sca I analysis in the ANP precursor gene (PCR followed by digestion with restriction enzymes) and to determine the frequencies of Sma I or Sca I genotypes and alleles in patients with sodium-sensitive (SS) or sodium-nonsensitive (SR) hypertension. The Sma I heterozygous mutation (WM genotype) were detected in 4 (8.9%) SS patients and in 2 (10%) patients in SR group. The frequency of Sca I M allele (allele with mutation) was significantly higher in SS group as compared to sodium-nonsensitive hypertensives. Our results suggest that, in contrast to Black hypertensives, in Caucasians with essential hypertension the Sma I polymorphism is very rare and the Sca I polymorphism of ANP precursor gene is associated with sodium-sensitivity of blood pressure.
Pol Arch Med Wewn 1998 Jul
PMID:[Analysis of polymorphisms Sma (Hpa II) and Sca I gene precursors of atrial natriuretic peptide (ANP) in patients with essential hypertension]. 1008 11

Adrenomedullin (ADM) is a novel peptide secretion from vascular smooth muscle, endothelial cells and other peripheral organs. It has potent and long-lasting vasodilatatory and natriuretic properties which could participate in regulating systemic blood pressure. To examine the pathophysiological role of ADM in hypertension the plasma concentrations of ADM were measured in patients with essential hypertension, before and after effective antihypertensive therapy, and in normotensive control group. Plasma ADM concentrations were increases in patients with severe hypertension and normal in patients with mild and moderate hypertension, and were decreased after effective therapy. In all hypertensive patients plasma ADM concentrations where not correlated with blood pressure, plasma renin activity, plasma endothelin-1,2, or plasma aldosterone. These results may suggest that ADM participates in defense mechanisms acting against the high elevation blood pressure in patients with hypertension.
Pol Merkur Lekarski 1998 Sep
PMID:[Plasma adrenomodullin concentration in patients wtih essential hypertension]. 1010 71

Outcomes of recently published studies showed that cause of primary hypertension may lay in dysregulation of one of physiological mechanisms. Accordingly to current knowledge one can state that disturbance of every of these mechanisms results in cascade of changes in function of sympathetic and endocrine systems with special impact in renin-angiotensin-aldosterone system. Better understanding of mechanisms underlying the pathogenesis of primary hypertension is crucial in development of such a treatment that not only reduces blood pressure but also prevents cardiovascular complications of hypertension.
Pol Merkur Lekarski 1998 Sep
PMID:[The role of neurohormonal mechanisms in the etiopathogenesis of essential hypertension]. 1010 86

The estimation of microcirculatory parameters in patients with essential hypertension and in normotensic control group was the aim of this study. The study group consisted of 14 patients with essential hypertension confirmed by 24-hours ABP. 10 healthy patients served as control group. The flow in the skin microcirculation was measured by laser-Doppler flowmeter (PF-3, PERIMED) on dorsal part of the palm. Microcirculatory indices were registered in resting conditions, during one-minute occlusion reaction and during reactive hyperemia. The following indices were calculated: resting flow, biological zero, maximal flow, time to maximal flow, ratio of maximal to resting flow, ratio of resting flow to biological zero and ratio of maximal flow to biological zero. Skin microcirculation was highly disturbed in patients with essential hypertension. It was expressed by significantly higher biological zero and longer time to maximal flow.
Pol Merkur Lekarski 1999 Feb
PMID:[Examination of skin microcirculation with laser-Doppler flowmetry in patients with essential hypertension]. 1033 75

The aim of this study was to investigate abnormalities in lymphocyte membrane sodium fluxes in patients with essential hypertension with and without familial history of hypertension and the influence of selected hypotensive drugs on these fluxes. 121 patients (pts) with positive family histories of primary hypertension (PFH) and 73 pts with negative family histories of primary hypertension (NFH) were examined. The total sodium efflux rate constant (wswc), ouabaine-sensitive (wswou) and furosemide-sensitive (wswf) were measured by the method of Heagerty et al. To examine the influence of selected hypotensive drugs on sodium fluxes wswc, wswou and wswf were measured before and after 7 days of treatment with hydrochlorothiazide (H) or propranolol (P). Wswou was decreased in 61% pts with PFH and in 19% pts with NFH, wswf was decreased in 38% pts with PFH and in 22% pts with NFH. Both, wswou and wswf, were decreased in 49% pts with PFH and only in 2.7% pts with NFH. Wswou and wswf rose significantly after 7 days of treatment with H or P only in pts with PFH and in pts with decreased wswou and wswf before treatment. These data suggest that abnormal lymphocytes membrane sodium transport often occurs in pts with PFH and has familial component. Changes in transport systems observed after 7 days treatment with H or P may contribute, at least in part, to its antihypertensive action in familial hypertension.
Pol Merkur Lekarski 1999 Mar
PMID:[Studies of lymphocyte membrane transport of sodium in patients with essential hypertension]. 1036 94


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>